2Coelho JM, Turton JF, Kaufmann ME,et al. Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England [J ]. J Clin Microbiol.2006 ,44(10) :3623 -3627
3Poirel L, Lebessi E, Heritier C,et al. Nosocomial spread of OXA58-positive carbapenem-resistant Acinetobacter baumannii isolates in a paediatric hospital in Greece[J]. Clin Microbiol Infect, 2006,12(11) :1138 - 1141
4Marchand IM, Damier-Piolle L, Courvalin P, et al. Expression of RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the adeRS two-component system[J]. Antimicrob Agents Chemother, 2004, 48(9) :3298 -3304
5Gbagaidi Haore H, Bertrand X, Muller A, et al. Are isolation measures needed in the hospital management of Acinetobacter baumannii colonizations-oinfections? [ J ]. Med Mal Infect. 2006,36(4) :201 -206
6Kraniotaki E, Manganelli R, Platsouka E, et al. Molecular investigation of an outbreak of multidrug-resistant Acinetobacter baumannii, with characterisation of class 1 integrons[J]. Int J Antimicrob Agents. 2006,28(3) :193 - 199
7Holloway KP, Rouphael NG, Wells JB, et al. Polymyxin B and doxycycline use in patients with multidrug-resistant Acinetohacter baumannii infections in the intensive care unit[J]. Ann Pharmacother. 2006 ,40( 11 ) :1939 - 1945
8Wareham DW, Bean DC. In-vitro activity of polymyxin B in combination with imipcncm, rifampicin and azithromycin versus multidrug resistant strains of Acinctobacter baumannii producing OXA23 carbapenemases[J]. Ann Clin Microbiol Antimicrob, 2006 ,5(1)5 -10
9Rahal JJ. Novel antibiotic combinations against infections with almost completely resistant Paeudomonas aeruginoaa and Acinetobaeter species[J]. Clin Infect Dis, 2006 ,43 (Suppl2) : 95 -99
10Rice LB. Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa [ J ] . Clin Infect Dis. 2006 , 43(Suppl2) :100 - 105
